Amgen Inc.
AMGN
$369.53
$1.930.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 35.15B | 34.50B | 33.51B | 32.78B | 32.03B |
| Total Other Revenue | 1.60B | 1.47B | 1.41B | 1.35B | 1.40B |
| Total Revenue | 36.75B | 35.97B | 34.92B | 34.13B | 33.42B |
| Cost of Revenue | 10.70B | 10.73B | 10.64B | 10.54B | 10.44B |
| Gross Profit | 26.05B | 25.24B | 24.28B | 23.58B | 22.98B |
| SG&A Expenses | 7.05B | 6.98B | 6.88B | 6.98B | 7.10B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 109.00M | 199.00M | 341.00M | 146.00M | 153.00M |
| Total Operating Expenses | 25.13B | 24.76B | 24.26B | 23.77B | 23.66B |
| Operating Income | 11.62B | 11.21B | 10.65B | 10.36B | 9.77B |
| Income Before Tax | 8.98B | 8.24B | 7.42B | 6.65B | 4.61B |
| Income Tax Expenses | 1.27B | 1.24B | 805.00M | 717.00M | 519.00M |
| Earnings from Continuing Operations | 7.71K | 7.01K | 6.62K | 5.93K | 4.09K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.71B | 7.01B | 6.62B | 5.93B | 4.09B |
| EBIT | 11.62B | 11.21B | 10.65B | 10.36B | 9.77B |
| EBITDA | 16.67B | 16.53B | 16.06B | 15.83B | 15.25B |
| EPS Basic | 14.33 | 13.02 | 12.31 | 11.04 | 7.62 |
| Normalized Basic EPS | 10.76 | 10.08 | 9.30 | 8.70 | 8.08 |
| EPS Diluted | 14.24 | 12.94 | 12.23 | 10.96 | 7.55 |
| Normalized Diluted EPS | 10.69 | 10.01 | 9.23 | 8.63 | 8.02 |
| Average Basic Shares Outstanding | 2.15B | 2.15B | 2.15B | 2.15B | 2.15B |
| Average Diluted Shares Outstanding | 2.17B | 2.17B | 2.17B | 2.17B | 2.16B |
| Dividend Per Share | 9.52 | 9.39 | 9.26 | 9.13 | 9.00 |
| Payout Ratio | 66.45% | 72.03% | 75.15% | 82.64% | 118.14% |